INTRODUCTION
Amyloidosis is a disease characterized by the deposition of altered proteins in tissues. 1 It is a pathological process encompassing a spectrum of disease that results from the extracellular deposition of fibrillar amyloid protein. 2 It is classified as primary or secondary disease. In both primary and secondary amyloidosis, the most commonly involved organ system is the gastrointestinal system, with the colon being the most frequently involved organ. 3 Hepatic involvement, secondary amyloidosis is common diffuse infiltration is the rule, but primary systemic amyloidosis (amyloid light [AL] chain) is an uncommon entity. 1 It may result in massive hepatomegaly, elevated serum alkaline phosphatase (ALP) levels and rapidly progressive liver failure. 4 To our knowledge, cases of amyloidosis involving the liver being presented as hepatic vein thrombosis have not been described previously but with IVC thrombus has been reported but that is in hepatic and GI systemic amyloidosis but not primary amyloidosis. 5, 6 Here we report a case of primary hepatic amyloidosis (HA) that presented with features of hepatic vein obstruction. The association of Budd-Chiari's syndrome with amyloidosis may be related to the increased risk of thrombosis observed in the latter disease.
Hepatic amyloidosis -primary AL type, sub nephrotic proteinuria and budd chairi syndrome -A nugget
We describe a case of 62-year-old gentleman presenting with abdominal pain associated with loss of weight nocturia, edema of feet, constipation, altered sleep rhythm and dyspepsia. On evaluation he had hepatomegaly with raised alkaline phosphatase and raised GGT levels with normal transaminases and bilirubin. On imaging he had diffuse enlargement of liver with heterogeneous contrast uptake in liver. His viral marker and autoimmune markers were negative. Liver biopsy depicted deposition of amorphous eosinophilic substance within the sinusoids which revealed apple green birefringence on polarizing microscopy after Congo red staining; Congophilia persisted even after treating with KMnO 4 . Abdominal fat pad was negative for amyloid deposit. Cardiac evaluation was unremarkable and renal evaluation showed Subnephrotic proteinuria and microhematuria. Serum and urine immunofixation electrophoresis showed positive kappa, lambda and gamma globulin. Immunoperoxidase staining for serum amyloid associated protein for secondary amyloidosis was negative from liver biopsy. Here we report a case of primary hepatic amyloidosis that presented with features of hepatic vein obstruction. The association of Budd-Chiari's syndrome, with amyloidosis may be related to the increased risk of thrombosis observed in the latter disease also due to loss of anticoagulants due to significant proteinuria. Patient could not be treated either with chemotherapy or with surgery. We lost him for progressive liver failure.
THE CASE
A Sixty-two years old gentleman, a landlord, presented with significant smoking and ethanol intake, with increased frequency of micturition, nocturia, significant weight loss 10 kgs in a span of 2 months, constipation, altered sleep rhythm, Past h/o umbilical hernia surgery, with ascites and significant weight loss. 
DISCUSSION
Here we report a case of primary hepatic amyloidosis that presented with features of hepatic vein obstruction. The association of Budd-Chiari's syndrome with amyloidosis may be related to the increased risk of thrombosis observed in the latter disease. Our patient had hepatomegaly with constitutional symptoms, features of hepatic failure together with raised alkaline phosphatase and GGT, Subnephrotic range proteinuria and micro hematuria, with features of prostatomegaly and Budd Chairi syndrome. Renal biopsy owing to his poor general condition and prostate biopsy was not done. Radiological findings of hepatic involvement are non-specific. Pre-contrast and contrast enhanced CECT abdomen reveals enlarged liver with three small focal lesions seen in segment VIII, V and VII measuring 4mm, 9x 11mm and 7 mm respectively. These lesions are not visualized in unenhanced scans and shows progressive enhancement in arterial, portal phase with intense enhancement in the venous phase. Lesions homogenizing in delayed scan. Heterogeneous enhancement of hepatic parenchyma in delayed phase. All hepatic veins are thrombosed with hypodense lumen more evident in the venous phase. Anti-SAA Immunoperoxidase staining from liver biopsy was also negative. Hereditary forms of amyloidosis including lysosome form were considered. There was no evidence of spontaneous rupture, cardiac, or nervous system involvement, tuberculosis, rheumatoid arthritis, SLE, crohns disease, or evidence of other common inflammatory diseases. However, renal involvement could not be established conclusively with renal biopsy.
Though amyloidosis is considered as a systemic disease, 10%-20% cases can be localized. 7 To our knowledge primarily isolated hepatic involvement of liver in amyloidosis has rarely been described in the literature. Though it is possible that the patient has yet exhibited the evidence of systemic disease, hepatic involvement can occur in both primary and secondary types of amyloidosis (AL/AA).
In primary amyloidosis fibrillar protein which is deposited is a fragment of the variable immunoglobulin either commonly by light (and/or rarely heavy) chain. Whereas in secondary type the protein is the amino acid terminus of the acute phase protein SAA. 7 Secondary amyloidosis with hepatic involvement can be seen in chronic inflammatory disorders and infections including multiple myeloma, tuberculosis, rheumatoid arthritis, familial Mediterranean fever, Crohn's disease, Reiter's syndrome, ankylosing spondylitis, Sjögren's syndrome, dermatomyositis, vasculitis, chronic osteomyelitis, bronchiectasis, cystic fibrosis, systemic lupus erythematosus (SLE).
7
In hepatic amyloidosis, extensive compression of hepatocytes by the amyloid deposits results in atrophy of hepatocyte. This occurs due to amyloid deposits in the liver parenchyma along the sinusoids & within the spaces of disse or within the blood vessel walls. Massive infiltration amyloid results in hepatomegaly with rubber elastic consistency. This results in "lardaceous liver" appearance on cut-surface. 8 The clinical spectrum of HA includes involuntary weight loss, Hepatomegaly was found in 79 patients (81%). Eightytwo patients (89%) had proteinuria, and 81 patients (86%) had elevated serum alkaline phosphatase levels. Seventy-six patients (83%) had either a serum or urine monoclonal protein. Hepatic ruputure and bleeding post liver biopsy was rare. Clinical suspicion of amyloidosis is also very challenging. The median survival rate in these patients is 8.5 months. 9 A study using antibodies against three different regions of immunoglobulin lambda light chain for the Immunohistochemical analysis of liver biopsy samples from the cases of immunoglobulin lambda light chain amyloidosis showed that the amyloid deposits may not be homogeneous in the liver and that molecular heterogeneity of amyloid fibril protein or a difference in the mode of deposition results in the histopathological heterogeneity of AL amyloid deposits. 10 Immunohistochemistry using anti-kappa and anti lambda antibodies are useful in Immunohistochemical classification and diagnosis of AL type amyloidosis. However it has its own limitations owing to cross reactivity between anti-kappa and anti-lambda antibodies. 10 There have been case reports of hepatic involvement in amyloidosis including one where the presentation was a liver SOL, in the setting of plasma cell dyscrasias, but isolated hepatic involvement is a rare entity, 2 with nephrotic syndrome, 3 intra hepatic cholestasis, 3, 4, 11, 12 Budd chairi syndrome. 5 Here we present a rare entity of isolated hepatic amyloidosis, with hepatic failure, Subnephrotic proteinuria and Budd chairi syndrome and gamma globulin, lambda and kappa positive. He was advised to undergo liver transplantation, he could not be initiated on chemotherapeutic agents, as he deteriorated and passed away. This case is a learning curve in the field of medicine, as diagnosis is challenging, and the treatment options available are also limited. "Written informed consent was obtained from the patient's kin for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal."
